Addressing Pneumococcal Disease in Latino Communities

Slides:



Advertisements
Similar presentations
Rotavirus vaccine impact. Introduction. Rotavirus vaccines lead to significant reductions in severe and fatal diarrhea in both vaccinated and unvaccinated.
Advertisements

Developing a Vaccine against Pneumonia, “The Captain of Death” -- Osler.
2014 UPDATES FROM THE CDC’S ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) William Schaffner, MD Professor of Preventive Medicine and Infectious Diseases.
Update on Pneumococcal Vaccines
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.
RPMS Immunization Package Training - Reports Version 8.5*1 Amy Groom, MPH IHS Immunization Program Manager.
1 1 Immunization Update 2011 Connecticut Immunization Teleconference April 19, 2011 William Atkinson, MD, MPH National Center for Immunization and Respiratory.
Splenectomy Vaccine Protocol PIDPIC Rationale Spleen clears encapsulated bacteria and infected erythrocytes Serves as one of the largest lymphoid.
Chris Knefelkamp, PharmD PGY2 Internal Medicine Resident Richard L. Roudebush VA Medical Center September 17, 2015 A SHOT IN THE DARK: PNEUMOCOCCAL PNEUMONIA.
Modeling of the effect of pneumococcal conjugate vaccination on carriage and transmission of Streptococcus pneumoniae in Kenyan children John Ojal KEMRI-Wellcome.
Prevnar Supply Update Peter R. Paradiso, Ph.D. Wyeth Vaccines.
GREAT PLAINS AREA 2014 GPRA FINAL RESULTS & BEST PRACTICES Janelle Trottier, MSW, LCSW Health Systems Specialist.
American Academy of Pediatrics, Committee on Infectious Diseases. Policy Updated Recommendations on the Use of Meningococcal Vaccines Pediatrics. doi:
 Carolyn A. Parry, MPH CDC Public Health Advisor Montana Immunization Program 2016 Regional Immunization Workshops.
Ocean State Immunization Collaborative 2016 State - Supplied Vaccine Workshop May 17, 2016.
1 13-valent pneumococcal conjugate vaccine (PCV13) – new ACIP recommendations 44 th National Immunization Conference April 21, 2010 Pekka Nuorti, MD, DSc.
Improving Pneumococcal Vaccination Rates David Diamant MD, Molly Benedum MD Center for Family Medicine Aim The aim is to increase awareness of pneumococcal.
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory.
Date of download: 9/17/2016 From: Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United.
Pneumococcal Vaccination Small group cases:Facilitator’s Guide
Table 1 Characteristics of study population, by pneumococcal vaccination status. From: Prior Pneumococcal Vaccination Is Associated with Reduced Death,
Toronto Invasive Bacterial Diseases Network
Recommended Timeline for Influenza Vaccinations
Calcium Deficiency.
Texas Department of State Health Services Dr
Essential Updates in Atopic Dermatitis:
Overview of Disparities
Modern Strategies for Basal Insulin Use in T2D
COPD Management.
The Nurse View: Overcoming Challenges Associated With Cancer Immunotherapy.
What’s new in 2010? (cont) New PCV 13 recommendations
Adult Immunization: Making the Most of Everyday Opportunities
Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period  J. Liñares, C. Ardanuy, R. Pallares, A.
Immunizing the Older Adult: Challenges and Opportunities
ACIP Recommended Vaccines for Adults – By Age
Do CNV Subtypes Matter for Prognosis, Diagnosis, and Treatment?
Addressing Disease Burden in Asthma
The State of Pneumococcal Disease Prevention
Pneumococcal Disease Prevention in Children: Issues in the Era of PCVs
Improving Management of Type 2 Diabetes in Hispanic/Latino Patients
Hyperhidrosis Is Burdensome!
Tackling Atopic Dermatitis
Improving Therapeutic Management of Huntington's Disease in Long-Term Care.
Tools to Address Adherence Issues in Patients With SIHD
Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.
Current and Emerging Strategies for Management of Moderate-to-Severe Atopic Dermatitis.
Combining Efforts for Older Drivers: Licensing Agencies, Occupational Therapists, and Clinicians.
Program Goals Overview Is NEDA a Reasonable Target?
Understanding and Addressing the Needs of Patients With AD
IBD Increases Risk for Vaccine-Preventable Diseases
Immunization Throughout the Life Course: What Is the Clinician's Role?
Insulin in Diabetes Management: Effective Patient Selection Is Key
Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?  Stefanie Desmet, Jan Verhaegen, Marc Van Ranst,
Daniel M. Musher, MD  Mayo Clinic Proceedings 
Nurse Practitioners: At the Forefront of HPV-Related Disease Prevention.
Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989–2008)  C. Esteva, L. Selva, M.F.
Program Goals Overview Is NEDA a Reasonable Target?
Changes in Streptococcus pneumoniae serotypes causing invasive disease with non- universal vaccination coverage of the seven-valent conjugate vaccine 
Clinical Microbiology and Infection
Improving Adult Immunization Rates
Sensitivity to immunity parameters.
Exploring the Use of Adeno-Associated Virus for Gene Therapy
Contribution of Vaccines to Life-Course Event-Free Health
Expert Perspectives.
MenB Update: Communicating the Imperative With Parents
Foundations of Asthma.
Serotype 10A in Invasive Pneumococcal Disease (IPD) Surveillance in New Jersey, April – September 2009 Samantha Pitts, MD, MPH CDC/CSTE Applied Epidemiology.
Biosimilars in Immune-Related Diseases
Key pneumonia risk factors assessed during maternal postnatal interview. Key pneumonia risk factors assessed during maternal postnatal interview. EPI:
Presentation transcript:

Addressing Pneumococcal Disease in Latino Communities

Pneumococcal Vaccination Rates in the United States

Latino Ethnic Groups

Latino Population in the United States

States With Largest Latino Population

Pneumococcal Disease

Localized Vs Invasive Pneumococcal Disease

Pneumococcal Pneumonia

Invasive Pneumococcal Disease

Invasive Pneumococcal Disease in Children in the United States

Case Fatality Rates in Invasive Pneumococcal Disease

Children at Increased Risk of Invasive Pneumococcal Disease

Pneumococcal Vaccines

Administering PCV13 to Adults

Administering PPSV23 To Adults

Administering PPSV23 to Adults (cont)

Administering PCV13 in Children

PCV13 Vaccination Schedule for Unvaccinated Older Children

Specific Risk Factors for Pneumococcal Disease in Latinos

Pneumococcal Vaccination Rates in the United States

Disparities in Pneumococcal Vaccination Rates

Barriers to Vaccination in Latinos

Strategies to Overcome Barriers and Close the Gaps

Concluding Remarks

Abbreviations